Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...

In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...

Are you searching for effective medications to treat 'Tuberculosis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.

Even if US foreign aid cuts are reversed, the damage to global TB control has already been done, says Saw Swee Hock School of ...

BHUBANESWAR : Odisha government has urged the Centre to streamline supply of anti-tuberculosis drugs to the state under National TB Elimination Programme (NTEP). In a letter to Union Health and ...

To discuss the implementation of Bedaquiline in the State, Prof Anil Koul (London School of Hygiene & Tropical Medicine) and VP research J&J and Prof Alok Dhawan (Director, Centre of Biomedical ...

It’s been three months since a global tuberculosis (TB) drug shortage was first reported. Motherwell Community Health Centre in Gqeberha, Eastern Cape is only left with five boxes of Rifinah, a ...